Greenleaf Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.8M Buy
85,086
+2,036
+2% +$474K 0.2% 36
2025
Q4
$17.2M Sell
83,050
-268
-0.3% -$53K 0.16% 44
2025
Q3
$15.4M Sell
83,318
-5,677
-6% -$973K 0.14% 50
2025
Q2
$13.6M Sell
88,995
-8,482
-9% -$1.3M 0.12% 55
2025
Q1
$16.2M Buy
97,477
+9,523
+11% +$1.49M 0.15% 48
2024
Q4
$12.7M Sell
87,954
-10,143
-10% -$1.57M 0.12% 56
2024
Q3
$15.9M Buy
98,097
+6,628
+7% +$1.06M 0.14% 49
2024
Q2
$13.4M Buy
91,469
+7,963
+10% +$1.18M 0.13% 52
2024
Q1
$13.2M Buy
83,506
+629
+0.8% +$100K 0.12% 55
2023
Q4
$13M Sell
82,877
-13,449
-14% -$2.06M 0.14% 51
2023
Q3
$15M Sell
96,326
-2,473
-3% -$408K 0.17% 38
2023
Q2
$16.4M Buy
98,799
+12,317
+14% +$1.99M 0.17% 38
2023
Q1
$13.4M Sell
86,482
-5,841
-6% -$943K 0.15% 44
2022
Q4
$16.3M Buy
92,323
+4,615
+5% +$797K 0.21% 31
2022
Q3
$14.3M Buy
87,708
+9,302
+12% +$1.57M 0.21% 37
2022
Q2
$13.9M Buy
78,406
+12,740
+19% +$2.27M 0.21% 33
2022
Q1
$11.6M Buy
65,666
+3,166
+5% +$539K 0.14% 39
2021
Q4
$10.7M Sell
62,500
-3,807
-6% -$623K 0.13% 43
2021
Q3
$10.7M Buy
66,307
+5,545
+9% +$946K 0.13% 41
2021
Q2
$10M Buy
60,762
+485
+0.8% +$80.3K 0.12% 42
2021
Q1
$9.91M Buy
60,277
+10,567
+21% +$1.71M 0.13% 42
2020
Q4
$7.82M Sell
49,710
-2,139
-4% -$316K 0.1% 44
2020
Q3
$7.72M Sell
51,849
-596
-1% -$88.2K 0.12% 43
2020
Q2
$7.38M Buy
52,445
+3,609
+7% +$526K 0.13% 43
2020
Q1
$6.4M Buy
48,836
+8,739
+22% +$1.24M 0.13% 40
2019
Q4
$5.85M Sell
40,097
-26,022
-39% -$3.53M 0.09% 53
2019
Q3
$8.55M Sell
66,119
-183
-0.3% -$24.1K 0.13% 37
2019
Q2
$9.23M Buy
66,302
+1,791
+3% +$248K 0.15% 38
2019
Q1
$9.02M Buy
64,511
+303
+0.5% +$40.6K 0.15% 37
2018
Q4
$8.29M Buy
64,208
+262
+0.4% +$36.5K 0.16% 32
2018
Q3
$8.84M Buy
63,946
+3,142
+5% +$418K 0.16% 36
2018
Q2
$7.38M Buy
60,804
+3,324
+6% +$415K 0.14% 42
2018
Q1
$7.37M Buy
57,480
+389
+0.7% +$52.6K 0.15% 37
2017
Q4
$7.98M Buy
57,091
+1,562
+3% +$218K 0.16% 34
2017
Q3
$7.22M Buy
55,529
+4,809
+9% +$637K 0.16% 38
2017
Q2
$6.71M Buy
50,720
+1,704
+3% +$217K 0.15% 39
2017
Q1
$6.11M Sell
49,016
-1,549
-3% -$185K 0.15% 42
2016
Q4
$5.83M Buy
50,565
+1,734
+4% +$200K 0.15% 50
2016
Q3
$5.77M Buy
48,831
+6,158
+14% +$747K 0.15% 48
2016
Q2
$5.18M Buy
42,673
+24,054
+129% +$2.73M 0.13% 51
2016
Q1
$2.02M Sell
18,619
-5,129
-22% -$531K 0.05% 64
2015
Q4
$2.44M Sell
23,748
-3,590
-13% -$361K 0.07% 55
2015
Q3
$2.55M Sell
27,338
-5,800
-18% -$561K 0.08% 38
2015
Q2
$3.23M Buy
33,138
+15,000
+83% +$1.5M 0.09% 36
2015
Q1
$1.82M Sell
18,138
-468
-3% -$47.6K 0.05% 53
2014
Q4
$1.95M Sell
18,606
-120
-0.6% -$12.6K 0.06% 53
2014
Q3
$2M Buy
18,726
+1,411
+8% +$146K 0.07% 48
2014
Q2
$1.8M Sell
17,315
-107
-0.6% -$10.8K 0.06% 58
2014
Q1
$1.71M Sell
17,422
-446
-2% -$41.3K 0.06% 56
2013
Q4
$1.64M Sell
17,868
-12,149
-40% -$1.12M 0.06% 60
2013
Q3
$2.6M Sell
30,017
-1,039
-3% -$93.2K 0.1% 44
2013
Q2
$2.67M Buy
+31,056
New +$2.64M 0.1% 43

Other funds holding JNJ

Greenleaf Trust's JNJ Position: Q1 2026 in Review

Greenleaf Trust increased its Johnson & Johnson (JNJ) stake by 2.5% in Q1 2026, buying an estimated $474K and bringing the position to 85,086 shares worth $20.8M. The position accounts for 0.2% of the portfolio, ranked #36.

Greenleaf Trust first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Greenleaf Trust held 85,086 shares of Johnson & Johnson worth $20.8M as of Q1 2026.
  • Greenleaf Trust bought 2,036 Johnson & Johnson shares in Q1 2026, an estimated $474K.
  • Johnson & Johnson made up 0.2% of Greenleaf Trust's portfolio in Q1 2026, its #36 holding.
  • Greenleaf Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.